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 Introduction 
 The identification of risk factors predicting drug re-
lapse is pivotal for detecting patients in need of special-
ized treatment interventions, i.e. better focused relapse 
prevention strategies, and developing new treatment in-
terventions targeted at this high-risk populations. A vast 
literature on prediction of relapse that classified the key 
predictors of alcohol relapse into four broad categories, 
sociodemographic (e.g. socioeconomic or employment 
status), clinical (e.g. comorbid psychopathology), psycho-
logical (e.g. self-report measures of impulsive personali-
ty, craving or stress), and cognitive (e.g. neurocognitive 
measures of decision-making and impulsivity)  [1] . In the 
last years, the treatment literature  [2–4] has paid particu-
lar attention to cognitive predictors because they offer a 
number of advantages over other predictors. Particularly, 
they are thought to reflect better the neurobiological al-
terations that define the chronic nature of addiction, and 
they are significantly associated with other risk factors, 
such as impulsivity, comorbid psychiatric disorders, or 
craving  [5] .
 Addicted individuals, irrespective of the main drug of 
choice, share generalized cognitive-executive deficits  [6] . 
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 Abstract 
 Background/Aims: Common and long-lasting deficits in de-
cision-making in polysubstance-dependent alcoholics (PSA) 
reflect neurobiological alterations that define the chronic 
nature of addiction. These deficits affect goal-directed be-
havior and might be critical risk factors predicting relapse in 
PSA.  Methods: The Delay Discounting Task (DDT) and the 
Iowa Gambling Task (IGT) assessed the delay-discounting 
and decision-making skills among 37 abstinent PSA.  Results: 
The findings indicated that IGT but not DDT performances 
were associated with 3-month abstinence, irrespective of 
the influence of personality traits and coexistent medica-
tions.  Conclusion: The results show that the IGT, which as-
sesses processes that are important in the latter stages of 
addiction, is ecologically more valid compared to the DDT, 
which assesses processes important in the early stages. They 
underline the importance of using neurocognitive measures 
to identify high relapse risk patients and emphasize the rel-
evance of promoting new treatments. 
 Copyright © 2012 S. Karger AG, Basel 
 Received: December 15, 2011 
 Accepted: May 7, 2012 
 Published online: August 28, 2012 
European
Addiction
cRe es ar h
 Bieke De Wilde, MA 
 Algemeen Ziekenhuis Stuivenberg, PAAZ
Lange  Beeldekensstraat 267 
 BE–2060 Antwerpen (Belgium) 
 Tel. +32 3 217 7763, E-Mail bieke.dewilde   @   zna.be 
 © 2012 S. Karger AG, Basel
1022–6877/13/0191–0021$38.00/0 
 Accessible online at:
www.karger.com/ear 
D
ow
nl
oa
de
d 
by
: 
62
.1
63
.1
07
.5
0 
- 5
/2
3/
20
16
 1
0:
22
:2
9 
PM
 De Wilde  /Verdejo-García  /Sabbe  /
Hulstijn  /Dom  
Eur Addict Res 2013;19:21–2822
However, deficits in delay-discounting, i.e. the ability to 
hold the subjective value of reinforcers even when their 
delivery is delayed, and decision-making, i.e. the ability 
to select long-term adaptive choices at the expense of 
risky options that offer a ‘superficially seductive’ gain, are 
particularly long-lasting  [7–9] . They are also tightly 
linked to durable neurobiological abnormalities, which 
persist in polysubstance abusers after 2–4 years of absti-
nence  [10] . Therefore, they are optimal candidates for 
predicting drug relapse outcomes after the treatment. 
These skills are also critical for the integration of cogni-
tive and emotional input that guide goal-directed behav-
ior towards long-term outcomes  [11] ; therefore, their con-
course may be fundamental to resisting the influence of 
well-known affective triggers of relapse, such as stress 
 [12] and states of positive or negative mood  [13] . In agree-
ment with these notions, available studies have shown 
that impaired decision-making is predictive of relapse in 
alcohol and opiate-dependent patients. It was found that 
alcohol- and opiate-dependent patients with impaired 
performance on the Iowa Gambling Task (IGT)  [14] and 
the Cambridge Gamble Task (CGT)  [15] were more likely 
to relapse after three months compared to the nonim-
paired probands  [16, 17] . Conversely, delay discounting 
failed to predict relapse, regardless of both probes shar-
ing similar neuropsychological demands  [18] . Although 
these findings illustrate the predictive power of decision-
making skills on drug relapse, some limitations warrant 
further investigation. In the Bowden-Jones et al.  [16] 
study, the alcohol patients who relapsed had higher base-
line impulsivity scores compared to abstainers, which 
may have confounded the results. Furthermore, in the 
study of Passetti et al.  [17] , opiate users were receiving 
substitution pharmacotherapy; therefore, the results may 
not apply to drug-free individuals attempting to main-
tain abstinence. A more general consideration relates to 
the representativeness of the samples. Patients demand-
ing treatment in Europe are characterized primarily by 
polysubstance dependence and comorbid psychopathol-
ogy, variables that previous studies have not considered. 
The effect of these variables should also be dissociated 
from the contribution of other sociodemographic and 
clinical factors.
 We therefore aimed to study the role of delay-dis-
counting, as measured by the Delay Discounting Task 
(DDT), and decision-making skills, as measured by the 
IGT, on predicting 3-month drug relapse in a sample
of drug-free polysubstance-dependent alcoholics (PSA). 
Both neurocognitive tasks have been frequently used. 
They are ecologically valid and believed to capture inde-
pendent aspects of impulsivity. The selected group of ad-
dicted patients is representative of the general population 
of patients demanding treatment in Europe  [19] for whom 
it is difficult to cease substance use  [20, 21] ; therefore, we 
expected to find a substantial percentage of relapse dur-
ing the first 3 months of abstinence. Moreover, PSA usu-
ally have comorbid personality disorders (PD), which in-
fluences decision-making  [22, 23] . Accordingly, we in-
cluded comorbid PD patients in the target sample to 
increase its clinical representativeness. We used a longi-
tudinal outcome study to examine the effect of delay dis-
counting and decision-making, along with sociodemo-
graphic, clinical (personality disorders), and psychologi-
cal variables (sensitivity to reward/punishment and trait 
impulsivity), on 3-month relapse. We predicted that the 
examined neurocognitive measures would have a direct 
effect on 3-month relapse. Clinical and psychological 
variables were examined as confounding variables, since 
they are known to affect addictions negatively. These 
variables thus might add to the effects of the neurocogni-
tive tasks.
 Subjects and Methods 
 Participants 
 Thirty-seven PSA were recruited from an addiction ward 
(Psychiatric Center Broeders Alexianen, Boechout, Belgium) 
based on the following criteria: age (18–55) and lifetime depen-
dence on at least three substances with the exception of caffeine 
and nicotine ( table  1 ). Participants were excluded when they 
showed signs of lifetime psychotic disorders (sources: clinical 
psychiatric Interview, Structured Clinical Interview for DSM 
disorders), organic deterioration or amnesic disorders, physical 
handicaps, severe somatic disorders, illiteracy, or mental retarda-
tion.
Table 1.  Alcohol and drug use
Age
of onset
Years of sub-
stance use
Range
Alcohol (n = 31) 19.4585.74 11.4886.96 1–7.5 l/day
Cocaine (n = 21) 23.6787.41 5.9584.03 0.5–70 g/week
Amphetamines
(n = 26) 18.9685.25 7.1984.96 1–30 g/week
Cannabis (n = 29) 17.0084.65 11.7987.43 5–25 g/week
MDMA (n = 24) 20.2586.88 5.3884.14 5–30 tablets/
 week
P atients used on average 4.89 8 2.01 substances. Substances 
were mentioned when at least half of the group abused them.
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 Sociodemographic, Clinical and Background Cognition 
Measures 
 • The European version of the Addiction Severity Index (Euro-
pASI)  [24] was used to assess patients’ substance use before the 
treatment. At follow-up, the alcohol and drug sections of the 
follow-up version of the EuropASI were used to determine 
whether PSA were abstainers or nonabstainers. The data were 
converted into dichotomous variables. PSA were considered 
abstinent if they reported no substance use (apart from caffeine 
and nicotine), while those who reported using substances in 
addition to caffeine and nicotine were considered relapsed. 
 • The Assessment of DSM-IV Personality disorders (ADP-IV) 
 [25, 26] is a self-report questionnaire comprising 94 phrases. 
Each phrase represents a DSM-IV axis-II criterion. Each 
phrase is measured on a seven-point Likert scale to form a trait 
score: How much do you agree with this statement about your-
self? Answers: 1 = totally disagree; 2 = disagree; 3 = tend to 
disagree; 4 = neither agree nor disagree; 5 = tend to agree; 6 = 
agree; 7 = fully agree. Typical criteria (trait score  6 5) are fur-
ther judged on a three-point Distress scale: Has this trait ever 
caused you or others any suffering or problems? Answers: 1 = 
not at all; 2 = to a degree; 3 = definitely. The T’5 (Trait score 
 6 5) and D’1 (Distress score  6 1) categorical diagnostic evalu-
ation algorithm was used to state the presence of DSM-IV ax-
is-II criteria. The diagnoses were made based on the presence 
of the DSM-IV criteria. 
 • The Raven Progressive Matrices (Raven PM)  [27] and the Rey 
Auditory Verbal Learning Test (AVLT)  [28] were used to esti-
mate intelligence and verbal memory. 
 Self-Report Measures of Impulsive Personality 
 • The Barratt Impulsiveness Scale  (BIS)  [29] , a self-report ques-
tionnaire (30 items), measured total, attentional, motor, and 
nonplanning facets of trait impulsivity. 
 • The  Sensitivity to Punishment and Sensitivity to Reward 
Questionnaires  (SPSRQ)  [30] measured personality traits as-
sociated with the behavioral activation or appetitive system 
(sensitivity to reward) and the behavioral inhibition system 
(sensitivity to punishment). 
 Cognitive Measures of Impulsivity and Decision-Making 
 • A computerized version of the DDT  [31] asked participants to 
choose between immediate (USD 10, 30 and 100) and delayed 
rewards (values adapted according to an adjusting amount 
procedure). The delays were set at 2, 30, 180, 360 or 720 days. 
 • IGT [based upon  14, 32 ] required participants to choose 100 
cards from four card decks (K’, L’, M’, N’). Each deck held 60 
cards with identical backs. Participants were instructed to se-
lect cards to earn as much money as possible. Unknown to 
them, card selections came with different pay-offs: good decks 
(K’M’) combined modest wins with small losses (net gains) 
while bad decks (L’, N’) combined large wins with even larger 
losses (net losses). Good decks gave net gains while bad decks 
led to net losses. Outcome measures were the mathematical 
differences between the number of cards picked from the ad-
vantageous decks and the number of cards picked from the 
disadvantageous decks, calculated for blocks of 20 cards. The 
K’L’M’N’ version is more difficult than the original ABCD and 
A’B’C’D’ version because it uses all pay-offs instead of simple 
multiplications of ten. 
 Procedure  ( fig. 1 ) 
 PSAs who entered the ward consecutively were asked about 
their substance use. A week later, verbal memory and intelligence 
were assessed. When they were abstinent for two weeks, PSAs 
completed the BIS and the SPSRQ. The DDT and the IGT were 
performed when PSAs were abstinent for 6 weeks. Regular urine 
screens were used to confirm abstinence. Three months after the 
treatment, PSAs were asked about their last-month substance use. 
They were considered abstinent if they reported no substance use 
(apart from caffeine and nicotine) (abstainers). They were consid-
ered relapsers if they used substances other than caffeine and nic-
otine (nonabstainers). Participants gave written informed con-
sent.
 The ethical committee of the University of Antwerp approved 
the procedure.
 Data Analytic Plan 
 This naturalistic outcome study compared two groups of in-
dividuals, abstinent and nonabstinent from alcohol and or illicit 
drugs, at three months. t and   2 tests were used to examine group 
differences in demographic, substance use, and personality dis-
orders variables. Group differences in personality traits (BIS-
SPSRQ) were found through general linear model (GLM) multi-
variate analyses. Group differences in neurocognitive measures 
(DDT-IGT) were tested with ANOVAs (GLM repeated measures). 
Week 1 Week 2 Week 3 Week 4 Week 5 Week 6 Week 7 Week 8 Week 9 Week 10
Observation
Substitution treatment
Active treatment
No substitution treatment
EuropASI MemoryIntelligence
BIS-
SPSRQ DDT-IGT
 Fig. 1. Research procedure. 
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Possible effects of the PD on the impulsivity and neurocognitive 
measures were examined by adding the PD (absent/present based 
upon the ADP-IV) as additional independent variable in the anal-
yses. None of these analyses changed the present findings. These 
data can be provided on simple request to the first author.
 Results 
 Demographic Variables 
 At follow-up, 11 males and 3 females were classified as 
abstainers while 18 males and 5 females were classified as 
nonabstainers. Mean age of both abstainers and non-
abstainers was 32 years. They both went to school for 
11 years. Abstainers (n = 14) and nonabstainers (n = 23) 
thus did not differ on demographic variables ( table 2 ).
 Substance Use, Clinical and Background Cognition 
Variables  ( table 2 ) 
 Abstainers and nonabstainers used alcohol and drugs 
for 15 years. However, abstainers were slightly older than 
nonabstainers when they started to use alcohol and drugs 
(marginally significant effect). The severity of their sub-
stance was similar.
 As shown in  table 2 , abstainers and nonabstainers dif-
fered in cluster C PD presence. PD presence or absence 
did not affect the self-report measures of impulsive per-
sonality or the cognitive measures of impulsivity and 
 decision-making.
 The groups finally did not differ on the AVLT and 
 Raven PM ( table 2 ).
 Self-Report Measures of Impulsive Personality  ( table 2 ) 
 As seen in  table 2 , abstainers and nonabstainers did 
not differ in BIS and SPSRQ scores.
 Cognitive Measures of Impulsivity and 
Decision-Making 
 GLM repeated measures analyses of variance with 
Block (Block 1 to 5) as within-subjects factor and Group 
(abstainers-nonabstainers) as between-subjects factor 
showed that abstainers and nonabstainers differed in IGT 
(F(1,35) = 5.264, p = 0.028). IGT performances also 
changed over Blocks (F(4,32) = 3.684; p = 0.014). There 
was no significant block  ! group interaction effect 
(F(4,32) = 0.299; p = 0.876) ( fig. 2 ). GLM repeated mea-
sures analyses of variance with amount (USD 10–100) as 
within-subject factor and group (abstainers vs. nonab-
stainers) as between-subject factors showed that abstain-
ers and nonabstainers did not differ in DDT (F(1,33) = 
0.422, p = 0.520). There also were no significant amount 
(F(2,32) = 2.534; p = 0.087) or amount  ! group interac-
tion effects (F(2,32) = 0.107; p = 0.898). Correlations be-
Table 2.  Dif ferences in demographic variables, substance use, 
clinical and background cognition measures, self-report mea-
sures of impulsive personality and cognitive measures of impul-
sivity and decision-making in PSA abstainers (n = 14) vs. PSA 
nonabstainers (n = 23)
Variables Abstainers Nonabstainers p
values
Gender    11 -/3 U    18 -/ 5 U NS
Cluster A PD 2 yes/12 no 5 yes/18 no NS
Cluster B PD 7 yes/7 no 7 yes/16 no NS
Cluster C PD 5 yes/9 no 2 yes/21 no <0.050
Age 32.2185.32 31.6887.88 NS
Years of education 11.3682.17 11.4182.56 NS
Age of onset 16.7184.70 14.4582.30 <0.100
Years of substance use 14.5786.25 15.3686.46 NS
EuropASI-alcohol 4.5783.03 4.7482.78 NS
EuropASI-drug 5.1481.61 5.3981.78 NS
Raven PM 46.2182.08 49.9681.62 NS
AVLT 106.4383.70 110.1782.89 NS
BIS-total 76.86811.12 78.2689.12 NS
BIS-attention 19.0084.30 19.9184.10 NS
BIS-motor 26.2985.90 26.4883.64 NS
BIS-nonplanning 31.5784.01 31.8784.17 NS
SPSRQ-SP 13.9387.18 12.6586.18 NS
SPSRQ-SR 14.1484.66 12.5784.27 NS
DDT-k-log NS
10 USD –1.4280.65 –1.5780.79
30 USD –1.4080.61 –1.6380.92
100 USD –1.5780.84 –1.7581.05
Values denote numbers or means 8 SD.
–2
0
2
4
6
8
Block 1 Block 2 Block 3 Block 4 Block 5
    
IG
T 
sc
or
es
 
 Fig. 2. IGT performances in abstainers (––––) and nonabstainers 
(– – –). 
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tween neurocognitive tasks and other important vari-
ables are found in  table 3 . Using these variables as covari-
ates did not influence the main results.
 Discussion 
 The main result of the present study is that decision-
making rather than delay discounting was associated 
with a 3-month abstinence in PSA. Psychological and 
clinical variables did not differ between abstainers and 
nonabstainers, thus increasing the specificity of predic-
tion related to cognitive variables, in agreement with our 
initial hypothesis.
 The subset of patients who relapsed into substance 
abuse within 3 months after the treatment had poorer 
decision-making performance compared to the patients 
who succeeded in maintaining abstinence. This is con-
sistent with previous research showing that relapsed al-
cohol  [16] and opiate-dependent patients  [17] performed 
significantly worse compared to nonrelapsed patients on 
neurocognitive probes at the 3-month follow-up. How-
ever, alcohol abstainers in the Bowden-Jones et al.  [16] 
 study had lower baseline impulsivity scores, which is a 
relevant confounder considering that low trait impulsiv-
ity is significantly predictive of better decision-making 
performance on the IGT  [33] . In addition, the opiate-
dependent patients included in the study of Passetti et al. 
[17]  were all stabilized on substitute opiate pharmaco-
therapy, which is known to affect decision-making skills 
 [34] , and may therefore influence outcome results. A 
number of other studies on cognitive predictors of out-
come, which have been developed in the context of clin-
ical trials testing CNS-active medications, share this 
limitation  [4] . In view of these specifications, our study 
is the first to demonstrate that decision-making skills 
predict drug relapse in previously stably abstinent (drug-
free) polysubstance abusers, irrespective of the influence 
of personality traits and co-existent medications. The 
present study is also first to demonstrate that decision-
making is a reliable predictor of relapse even when ab-
stainers and nonabstainers are equally impulsive. This 
finding is in line with data on pathological gamblers 
 [35] .
 The finding that the abstainers and nonabstainers did 
not differ on delay discounting conflicts with our initial 
hypotheses but is consistent with the data of Passetti et 
al.  [17] showing that a 3-month abstinence was not as-
sociated with DDT performances in a group of opiate-
dependent patients. Although both tasks have shown to 
correlate significantly  [18] , a number of factors can ac-
count for the variation in their predictive value. First, 
unlike the DDT, the IGT factors in a number of aspects 
that are more representative of real-life decision-mak-
ing, including immediate rewards confronted by the 
prospect of potential punishments and decisions involv-
ing both risk and uncertainty of outcomes. These as-
pects are thought to increase the ecological validity of 
the IGT and its ability to predict specific problems per-
taining to addicted populations  [36] . A second factor re-
lates to the notion that the DDT assesses choices be-
tween short and long-term outcomes, whereas the IGT 
Table 3.  Correlations between neurocognitive measures and other important variables
Age Onset Duration BIS SPSRQ-SP SPSRQ-SR Log-k-100 IGT
Age 1.000 0.175 0.670** –0.143 0.081 0.130 –0.200 –0.112
Onset 1.000 –0.312 –0.132 –0.090 –0.011 –0.041 0.095
Duration 1 –0.059 0.147 0.250 –0.216 –0.106
BIS 1.000 0.318 0.103 0.119 –0.109
SPSRQ-SP 1.000 0.052 0.142 –0.095
SPSRQ-SR 1.000 –0.435* 0.189
log-k-100 1.000 0.020
IGT 1.000
O nset = Age of onset; duration = years of substance dependence; BIS = total score of the Barratt Impulsiveness Scale; SPSRQ-SP/
SPSRQ-SR = Sensitivity to Punishment and Sensitivity to Reward Questionnaires-Sensitivity to Punishment/Sensitivity to Reward;
log-k-100 = outcome measure of the DDT; IGT = Iowa Gambling Task net score (compound score over the blocks).
* p < 0.010; ** p < 0.001.
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assesses choices between outcomes with particular prob-
abilities  [18] . One might hypothesize that the processes 
involved in the DDT are more important to the early 
stages of addiction, when people are driven by attractive 
short-term effects, but relatively blind to the long-term, 
less-attractive effects of substance use. Conversely, the 
processes involved in the IGT are more important to the 
latter stages of addiction, when people understand the 
likelihood of the short- and long-term consequences of 
drug use but may have problems adjusting motivational 
preferences to expected outcomes  [37, 38] . In agreement 
with this notion, the findings demonstrated that impul-
sive action was associated with the initiation/mainte-
nance of nicotine self-administration in rats while im-
pulsive choice was associated with diminished abilities 
to withhold nicotine reinstatement  [39] . Impulsive ac-
tion hereby refers to poor inhibitory control resulting 
from deficits in the ability to withhold responding while 
impulsive action refers to impulsive decision-making re-
sulting from an insensitivity to delay of gratification or 
aversion. Germane to this, different strands of evidence 
also suggest that difficulties in reversal learning can ex-
plain impaired IGT performances  [37, 40] , meaning that 
participants do not shift their preferences away from the 
initially rewarding decks to the latter rewarding decks. 
This agrees with recent views of the neurocircuitry of the 
addictive processes, which is thought to transit from
impulsivity (choices guided by acute reinforcement) to 
compulsivity (inability to reverse habitual response pat-
terns). These models, however, are found mainly in ani-
mal literature  [41, 42] .
 As in other studies, we found a high comorbidity with 
co-occurring personality disorders in our clinical sample 
 [43, 44] . Interestingly, cluster B diagnosis did not increase 
the risk of drug relapse, despite it being traditionally con-
sidered an important clinical variable with a negative ef-
fect on treatment outcome  [44] . Therefore, our data sup-
port the hypothesis that underlying cognitive skills rath-
er than heterogeneous clinical syndromes or estimates of 
problem severity (e.g. ASI scores) are better predictors of 
maintaining abstinence. Along the same lines, the find-
ing that more patients with a cluster C personality disor-
der did succeed abstinence is consistent with the data of 
Werner et al.  [45] showing better decision-making per-
formances in high trait anxiety participants. These re-
searchers suggested an inverted U-shape association be-
tween trait anxiety (the main characteristic of this clus-
ter) and decision-making. To incorporate the data of Miu 
et al. [46] , they argued that patients with both low and 
extreme trait anxiety tend to show poor decision-making 
performance, whereas patients with moderate anxiety 
tend to have superior decision-making skills. Our group 
thus seemed to obtain intermediate scores.
 Overall, our results add to the evidence that deficits in 
IGT performances are associated with a higher risk of re-
lapse and poor outcomes among substance-dependent 
patients. As of yet, it remains unclear whether these defi-
cits reflect premorbid vulnerability factors or the effects 
of the neurotoxicity due to the prolonged and intensive 
substance use. To support the former, research findings 
show an association between deficits in behavioral mea-
sures of impulsivity and addictive behaviors in adoles-
cents some years after administering the behavioral mea-
sures  [47–49] . In support of the latter hypothesis, recent 
findings in animal studies demonstrated that decision-
making deficits were a direct result of consuming high 
levels of alcohol during adolescence  [50] . Whether these 
results can be extrapolated to adult substance abusers re-
mains to be explored.
 Our findings may have important clinical implica-
tions. First, they underline the importance of using neu-
rocognitive measures when identifying high relapse risk 
patients in clinical populations. Second, they stress
the relevance of promoting new treatment interven-
tions, both pharmacological and psychosocial, targeted
at strengthening decision-making abilities  [51] .
 The main strength of the study is that it used a large 
sample representative of current real-world clinical pop-
ulations  [52] . This implies that the present findings can 
not only be used easily in clinical practice, but they can 
also be generalized to an important number of sub-
stance-dependent patients in need of effective treatments 
 [20, 21] . An additional strength of the present study is the 
inclusion of many possible confounding variables, like 
the PD, which have been found to relate to the decision-
making variables  [53–55] . A possible weakness of the 
present study is the choice of the outcome parameter. In 
line with the EuropASI follow-up, relapse was defined as 
any substance use within the last 30 days prior to the 
follow-up interview. This approach originates from the 
idea that substance-dependent patients either relapse 
soon after the end of their treatment or do not relapse at 
all  [56, 57] . In our study, 2 patients relapsed soon after 
the end of the treatment but attained abstinence in the 
last month prior to the follow-up interview. We made the 
analyses with and without those 2 patients and found 
similar results. We thus believe that the choice of our 
outcome parameter, which has been used in comparable 
research, is justified  [16, 17] . Further, we did not perform 
urine analyses at the follow-up interview. However, 
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whenever possible, patient reports were compared to rel-
atives’ reports, and since these reports were in agreement 
with each other, it was believed that patients’ reports of 
substance use were accurate. Though we checked for 
many confounding variables, we did not manage to cap-
ture them all. Craving, a factor known to affect relapse, 
could be a confounding variable that we did not include 
in our analysis. Thus, future research should consider 
craving and other factors mentioned in the study of 
Reske and Paulus  [1] .
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